Homepage of the supplier of Sucraid(TM)
Learn more about:
Related Access Program
Sucraid® is the first and only pharmacological therapy approved by the FDA as a simple, safe and effective enzyme replacement therapy of the genetically determined sucrase deficiency which is part of congenital sucrase-isomaltase disease (CSID).